Hematopoietic Stem Cell Mobilization for Gene Therapy: Superior Mobilization by the Combination of Granulocyte–Colony Stimulating Factor Plus Plerixafor in Patients with β-Thalassemia Major

Documenti analoghi

• Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in beta-thalassemia major patients
  di: Constantinou, Varnavas C., et al.
  Pubblicazione: (2016)
• Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
  di: Yannaki, Evangelia, et al.
  Pubblicazione: (2012)
• The Functional Effect of Repeated Cryopreservation on Transduced CD34(+) Cells from Patients with Thalassemia
  di: Karponi, Garyfalia, et al.
  Pubblicazione: (2018)
• Plerixafor+G-CSF–mobilized CD34(+) cells represent an optimal graft source for thalassemia gene therapy
  di: Karponi, Garyfalia, et al.
  Pubblicazione: (2015)
• Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model
  di: Psatha, Nikoleta, et al.
  Pubblicazione: (2014)